Probiotic Pediococcus pentosaceus strain GS4 alleviates azoxymethane-induced toxicity in mice

Nutrition Research

Volumn 35, Issue 10, 2015, Pages 921-929

  Dubey, Vinay ^a   Ghosh, Asit R ^a   Bishayee, Kausik ^b   Khuda Bukhsh, Anisur R ^b  

^a VIT UNIVERSITY   (India)

^b UNIVERSITY OF KALYANI   (India)

Author keywords

Azoxymethane; Brush border membrane; Hepatotoxicity; Mice; Probiotic

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; AZOXYMETHANE; LACTASE; PROBIOTIC AGENT; SUCRASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTERIAL LOAD; BACTERIAL STRAIN; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG SAFETY; ENTEROPATHY; HISTOPATHOLOGY; LIVER FUNCTION; LIVER PROTECTION; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NONHUMAN; PEDIOCOCCUS PENTOSACEUS; PRIORITY JOURNAL; RENAL PROTECTION; TISSUE LEVEL; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; DRUG-INDUCED LIVER INJURY; ENZYMOLOGY; INTESTINE; INTESTINE FLORA; KIDNEY DISEASES; METABOLISM; PEDIOCOCCUS; PERITONEUM; PHYSIOLOGY;

ALKALINE PHOSPHATASE; ANIMALS; AZOXYMETHANE; DRUG-INDUCED LIVER INJURY; GASTROINTESTINAL MICROBIOME; INTESTINES; KIDNEY DISEASES; LACTASE; MICE; PEDIOCOCCUS; PERITONEUM; PROBIOTICS; SUCRASE;

EID: 84941806511     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2015.08.001     Document Type: Article

References (44)

1. Haggar F.A., Boushey R.P. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg 2009, 22:191-197.
2. Watson A.J., Collins P.D. Colon cancer: a civilization disorder. Dig Dis 2011, 29:222-228.
3. Triantafillidis J.K., Nasioulas G., Kosmidis P.A. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. Anticancer Res 2009, 29:2727-2737.
4. Campos F.G., Logullo Waitzberg A.G., Kiss D.R., Waitzberg D.L., Habr-Gama A., Gama-Rodrigues J. Diet and colorectal cancer: current evidence for etiology and prevention. Nutr Hosp 2005, 20:18-25.
5. Simmonds P.C., Primrose J.N., Colquitt J.L., Garden O.J., Poston G.J., Rees M. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 2006, 94:982-999.
6. Stein U., Walther W., Arlt F., Schwabe H., Smith J., Fichtner I., et al. MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med 2009, 15:59-67.
7. Reddy B.S., Kawamori T., Lubet R.A., Steele V.E., Kelloff G.J., Rao C.V. Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process. Cancer Res 1999, 59:3387-3391.
8. Österlund P., Ruotsalainen T., Korpela R., Saxelin M., Ollus A., Valta P., et al. Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study. Br J Cancer 2007, 97:1028-1034.
9. Zitvogel L., Galluzzi L., Viaud S., Vétizou M., Daillère R., Merad M., et al. Cancer and the gut microbiota: an unexpected link. Sci Transl Med 2015, 7:271. [ps1]. 10.1126/scitranslmed.3010473.
10. Kobaek-Larsen M., Fenger C., Ritskes-Hoitinga J. Secondary effects induced by the colon carcinogen azoxymethane in BDIX rats. APMIS 2004, 112:319-329.
11. Lahouar L., Ghrairi F., Arem A.E., Sghaeir W., Felah M.E., Salem H.B., et al. Attenuation of histopathological alterations of colon, liver and lung by dietary fibre of barley Rihane in azoxymethane-treated rats. Food Chem 2014, 149:271-276.
12. Sohn O.S., Fiala E.S., Puz C., Hamilton S.R., Williams G.M. Enhancement of rat liver microsomal metabolism of azoxymethane to methylazoxymethanol by chronic ethanol administration: similarity to the microsomal metabolism of N-nitrosodimethylamine. Cancer Res 1987, 47:3123-3129.
13. BeDlanger M., Côté J., Butterworth R.F. Neurobiological characterization of an azoxymethane mouse model of acute liver failure. Neurochem Int 2006, 48:434-440.
14. Bolt M.J., Mailloux R.J., Rasenick M.M., Wali R.K., Skarosi S., Bissonnette M., et al. Expression of G protein a subunits in normal rat colon and in azoxymethane-induced colonic neoplasms. Gastroenterology 1998, 115:1494-1503.
15. Yoshida K., Nakamura W., Hirano K., Yuasa H., Tsukamoto T., Tatematsu M. Expression of sucrase and intestinal-type alkaline phosphatase in colorectal carcinomas in rats treated with methylazoxymethanol acetate. J Cancer Res Clin Oncol 1998, 124:677-682.
16. Klimesova K., Kverka M., Zakostelska Z., Hudcovic T., Hrncir T., Stepankova R., et al. Altered gut microbiota promotes colitis-associated cancer in IL-1 receptor-associated kinase M deficient mice. Inflamm Bowel Dis 2013, 19:1266-1277.
17. Guinane C.M., Cotter P.D. Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ. Ther Adv Gastroenterol 2013, 6:295-308.
18. Imani Fooladi A.A., Mahmoodzadeh Hosseini H., Nourani M.R., Khani S., Alavian S.M. Probiotic as a novel treatment strategy against liver disease. Hepat Mon 2013, 13:e7521-e7532.
19. El-Nezami H.S., Polychronaki N.N., Ma J., Zhu H., Ling W., Salminen, et al. Probiotic supplementation reduces a biomarker for increased risk of liver cancer in young men from Southern China. Am J Clin Nutr 2006, 83:1199-1203.
20. Sharma S., Chaturvedi J., Chaudhari B.P., Singh R.L., Kakkar P. Probiotic Enterococcus lactis IITRHR1 protects against acetaminophen-induced hepatotoxicity. Nutrition 2012, 28:173-181.
21. Goyal N., Rishi P., Shukla G. Lactobacillus rhamnosus GG antagonizes Giardia intestinalis induced oxidative stress and intestinal disaccharide enzymes: an experimental study. World J Microbiol Biotechnol 2013, 29:1049-1057.
22. Mechoud M.A., Juarez G.E., de Valdez G.F., Rodriguez A.V. Lactobacillus reuteri CRL 1098 and Lactobacillus acidophilus CRL 1014 differently reduce in vitro immunotoxic effect induced by Ochratoxin A. Food Chem Toxicol 2012, 50:4310-4315.
23. Gratz S.W., Mykkanen H., El-Nezami H.S. Probiotics and gut health: a special focus on liver diseases. World J Gastroenterol 2010, 16:403-410.
24. Sukumar G., Ghosh A.R. Pediococcus spp.-a potential probiotic isolated from Khadi (an Indian fermented food) and identified by 16S rDNA sequence analysis. Afr J Food Sci 2010, 4:597-602.
25. Sukumar G., Ghosh A.R. Anti-oxidative potential of probiotic bacteria from Indian fermented food. Int J Res Ayurv Pharm 2011, 2:983-986.
26. Bagad M., Pande R., Ghosh A.R. Determination of viability of Pediococcus spp. After storage into hard gelatin capsule and its survival under in vitro simulated gastrointestinal condition. Int J Res Ayurv Pharm 2012, 3:233-237.
27. Dubey V., Ghosh A.R., Mandal B.K. Appraisal of conjugated linoleic acid production by probiotic potential of Pediococcus spp. GS4. Appl Biochem Biotechnol 2012, 168:1265-1276.
28. Iyer C., Kosters A., Sethi G., Kunnumakkara A.B., Aggarwal B.B., Versalovic J. Probiotic Lactobacillus reuteri promotes TNF induced apoptosis in human myeloid leukemia derived cells by modulation of NF-kappa B and MAPK signalling. Cell Microbiol 2008, 10:1442-1452.
29. Guarner F., Khan A.G., Garisch J., Eliakim R., Gangl A., Thomson A., et al. Probiotics and prebiotics. World Gastroenterol Organization Practice Guidelines 2008.
30. Hosono K., Endo H., Takahashi H., Sugiyama M., Uchiyama T., Suzuki K., et al. Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase. Mol Carcinog 2010, 49:662-671.
31. Carleton H. Histological techniques 1980, Oxford University Press, New York, USA. 4th ed.
32. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
33. Dahlqvist A. Method for assay of intestinal disaccharides. Anal Biochem 1964, 7:18-25.
34. Dommels Y.E., Kemperman R.A., Zebregs Y.E., Draaisma R.B., Jol A., Wolvers D.A., et al. Survival of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the human gastrointestinal tract with daily consumption of a low-fat probiotic spread. Appl Environ Microbiol 2009, 75:6198-6204.
35. Festing M.F., Altman D.G. Guidelines for the design and statistical analysis of experiments using laboratory animals. ILAR J 2002, 43:244-258.
36. Wang Y., Li Y., Xie J., Zhang Y., Wang J., Sun X., et al. Protective effects of probiotic Lactobacillus casei Zhang against endotoxin- and d-galactosamine-induced liver injury in rats via anti-oxidative and anti-inflammatory capacities. Int Immunopharmacol 2013, 15:30-37.
37. Southcott E., Tooley K.L., Howarth G.S., Davidson G.P., Butler R.N. Yoghurts containing probiotics reduce disruption of the small intestinal barrier in methotrexate-treated rats. Dig Dis Sci 2008, 53:1837-1841.
38. Demirera S., Ulusub N.N., Aslimc B., Kepenekcia I., Ulusoyd C., Andrieu M.N., et al. Protective effects of Lactobacillus delbrueckii subsp bulgaricus B3 on intestinal enzyme activities after abdominal irradiation in rats. Nutr Res 2007, 27:300-305.
39. Urdaneta E., Barrenetxe J., Aranguren P., Irigoyen A., Marzo F., Ibáñez F.C. Intestinal beneficial effects of kefir-supplemented diet in rats. Nutr Res 2007, 27:653-658.
40. Diop L., Guillou S., Durand H. Probiotic food supplement reduces stress-induced gastrointestinal symptoms in volunteers: a double-blind, placebo-controlled, randomized trial. Nutr Res 2008, 28:1-5.
41. Reikvam D.H., Erofeev A., Sandvik A., Grcic V., Jahnsen F.L., Gaustad P., et al. Depletion of murine intestinal microbiota: effects on gut mucosa and epithelial gene expression. PLoS One 2011, 6:e17996-e18008.
42. Ling Z., Liu X., Cheng Y., Luo Y., Yuan L., Li L., et al. Clostridium butyricum combined with bifidobacterium infantis probiotic mixture restores fecal microbiota and attenuates systemic inflammation in mice with antibiotic-associated diarrhea. Biomed Res Int 2015, 2015:582048-582056.
43. Gkouskou K.K., Deligianni C., Tsatsanis C., Eliopoulos A.G. The gut microbiota in mouse models of inflammatory bowel disease. Front Cell Infect Microbiol 2014, 4:28-35.
44. Gopal P.K., Prasad J., Gill H.S. Effects of the consumption of Bifidobacterium lactis HN019 (DR10™) and galacto-oligosaccharides on the microflora of the gastrointestinal tract in human subjects. Nutr Res 2003, 23:1313-1328.